Board and Advisors

Board of Directors

Kathleen Sebelius

Kathleen Sebelius is one of America’s foremost experts on national and global health issues, human services and executive leadership. From April 2009 through June 2014, Kathleen served in President Barack Obama’s Cabinet as the 21st Secretary of the Department of Health and Human Services, leading the effort to pass and implement the most significant health reform in half a century–the Affordable Care Act. Kathleen served as Governor of Kansas from 2003 to 2009, and has led numerous ambitious efforts at the state and federal level to provide all Americans with the opportunity and tools to live happier, healthier and more successful lives.

Kathleen currently serves as a senior advisor to Enhanced Pharma, Hampton Creek Inc., and the Aspen Institute, where she co-chairs the Aspen Health Strategy Group. Named by Forbes as one of the 100 most powerful women in the world, Kathleen is a frequent keynote speaker for national and international organizations. Kathleen earned a master of public administration degree from the University of Kansas and a bachelor of arts degree from Trinity Washington University.

Owen Tripp

Co-Founder & CEO

As co-founder and CEO of Grand Rounds, Owen believes that patients will achieve better healthcare outcomes through the intersection of technology, medical expertise, and extraordinary patient care. Prior to Grand Rounds, Owen co-founded and grew the company into the worldwide leader in online reputation and privacy management; he also held leadership positions at eBay and Accenture (Health and Life Sciences Practice). Owen received a BA with honors from Trinity College and received an MBA from Stanford Graduate School of Business. Owen’s been recognized among the World Economic Forum’s Global Technology Pioneers, Goldman Sachs’ Top 50 Builders + Innovators and Rock Health’s Most Beloved CEOs.

Bryan Roberts

Bryan joined Venrock as a Kauffman Fellow in 1997. He is based in Venrock’s Palo Alto office and focuses on a broad range of healthcare investments. Bryan is currently Chairman of the Board of Directors of Achaogen, Castlight Health, and Ironwood Pharmaceuticals (NASDAQ: IRWD), in addition to serving on the Board of several other private companies. Past investments include athenahealth (NASDAQ: ATHN), Illumina (NASDAQ: ILMN) and Sirna Therapeutics (acquired by Merck). Bryan was named a Henry Crown Fellow by the Aspen Institute in 2006 and has been the highest-ranking healthcare investor on Forbes’ Midas List since 2008.

Immediately prior to joining Venrock, Bryan received his PhD in Chemistry & Chemical Biology from Harvard University. He previously held positions in corporate finance at Kidder, Peabody & Co and received his BA from Dartmouth College.

Lawrence “Rusty” Hofmann, MD


Dr. Hofmann co-founded Grand Rounds with the goal of ensuring that access to state-of-the-art care is available to everyone, not just the rich and privileged. He is Chief of Interventional Radiology at Stanford Hospital and a Professor of Radiology at the Stanford School of Medicine. A nationally recognized deep venous thrombosis (DVT) expert, Dr. Hofmann has published over 100 articles on acute and chronic DVT, peripheral arterial disease, and interventional oncology. Dr. Hofmann has a BS in Biology from University of Illinois and an MD from Ohio State University College of Medicine, and he did his residency at Johns Hopkins where he was Chief Resident.

Michael Dearing

Michael Dearing is the Founder of Harrison Metal. Prior to Harrison Metal, Michael spent many years at eBay (NASDAQ – EBAY), where he worked as Senior Vice President & General Merchandise Manager for In that role, he led category management, product marketing, seller development, eBay Stores and direct-to-consumer marketing for eBay North America. Michael was also responsible for the launch and growth of many new merchandise categories and new businesses, such as Buy-it-Now, listings upgrades, eBay Stores and ProStores.

Michael holds an AB in Economics with a focus in economic history from Brown University, as well as an MBA with Distinction from Harvard Business School.

James Slavet

James is a Partner at Greylock and invests in mission-driven entrepreneurs who combine technology and human touch to deliver amazing consumer services. James’ current investments include CreativeLive (online creative education), GoFundMe (crowdfunding for personal causes), Lyra Health (software-enabled service for mental health care), and Redfin (tech-enabled real estate brokerage). He invests in online marketplaces, e-commerce, end-to-end consumer services and business-to-business-to-consumer (B2B2C) models. James has backed multiple companies that have scaled from early stages to hundreds of millions in annual revenue. He has also represented Greylock as a Board member of companies that have been acquired by Adobe, Discovery Communications, Facebook, Microsoft, Twitter and Yahoo!.

Prior to Greylock, James was a VP/GM in the Search & Marketplace business unit at Yahoo!. He’s also worked in product development and operations roles in several early-stage consumer technology companies, including Guru (acquired by Unicru), (acquired by Walgreens), and Wired (acquired by Conde Nast). James has been named several times to the Forbes Midas list, which recognizes top VC tech investors. He graduated from Brown University and Harvard Business School.

Medical Advisory Board

Dr. Laura Esserman

Medical Advisory Board

Dr. Esserman is Professor of Surgery and Radiology at UCSF School of Medicine and directs the UCSF Carol Franc Buck Breast Care Center. Her research focuses on bioinformatics, medical and clinical informatics, systems integration, and clinical care delivery with the goal of giving patients better access to accurate information to become partners in their healthcare decisions. Dr. Esserman has authored numerous articles in peer-reviewed journals covering all aspects of breast health, advocating the improvement in delivering breast cancer care. She was awarded for her research and collaboration with colleagues when she received the 2005 NCI SPORE Investigator of the Year Award.

Dr. Keith Lillemoe

Medical Advisory Board

Dr. Lillemoe is Chairman of Surgery at Massachusetts General Hospital and the W. Austen Professor of Surgery at Harvard Medical School. He is a world-renowned general surgeon and regarded as one of the top pancreatic cancer surgeons in the country. With over four decades in academic medicine, Dr. Lillemoe has previously held leadership positions at Johns Hopkins and Indiana University. His bibliography includes more than 300 scientific articles and 115 book chapters. In addition, he serves as editor of the leading surgical textbook, Greenfield’s Surgery: Scientific Principles and Practices, and as the Editor-in-Chief of the top surgical journal, Annals of Surgery.

Dr. Ray Dorsey

Medical Advisory Board

Dr. Dorsey is Associate Professor of Neurology at The Johns Hopkins School of Medicine and Director of The Johns Hopkins Parkinson’s Disease and Movement Disorders Center. After receiving a joint MD/MBA at the University of Pennsylvania, Dr. Dorsey completed an NIH-funded fellowship in Movement Disorders and Experimental Therapeutics at the University of Rochester. His research focuses on movement disorders like Parkinson’s and Huntington’s disease and developing new treatments for individuals with these neurological conditions.

Dr. Michael Link

Medical Advisory Board

Dr. Link is the Lydia J. Lee Professor in Pediatric Cancer and former Chief of Pediatric Hematology & Oncology at Stanford University School of Medicine. He recently ended his term as President of the American Society of Clinical Oncology (ASCO) and was the first pediatric oncologist to serve in that position. Dr. Link runs multiple clinical trials at Stanford dealing with the treatment of sarcomas of bone and soft tissue, acute lymphoblastic leukemias, and non-Hodgkin’s lymphoma and Hodgkin’s disease. In 2013 he was awarded the visiting lectureship in Pediatric Oncology at the University of Texas MD Anderson Cancer Center.

Dr. Matthew Nielsen

Medical Advisory Board

Dr. Nielsen is a board-certified urologic oncologist practicing in the fully integrated Multidisciplinary Genitourinary Oncology Program at the UNC Chapel Hill Lineberger Comprehensive Cancer Center, where he is Director of the Division of Urologic Oncology. His research, focused on cancer care quality and medical decision making, was recognized with the Rising Stars in Urology Research Award and has been supported by the NIH, AHRQ, and the American Cancer Society. Dr. Nielsen received an M.S. in Clinical Research from UNC-Chapel Hill, did his residency at John Hopkins, and his received his M.D. from John Hopkins. He was selected for the American Urological Association Leadership Program and serves on the Scientific Advisory Board for the Bladder Cancer Advocacy Network.

Dr. Lidia Schapira

Medical Advisory Board

Dr. Schapira is an Associate Professor of Oncology at the Stanford University Medical Center. Her clinical area of expertise is in breast cancer, new treatments for the disease and the special concerns for young cancer survivors. Her research focuses on the psychosocial support of cancer patients and improved communication between the patient and treating physician. Dr. Schapira has published articles in the leading scientific and academic journals in the field and is a past director of the American Psychosocial Oncology Society.

Dr. Christopher Longhurst

Medical Advisory Board

As Chief Information Officer for UC San Diego Health, Dr. Longhurst oversees all operations and strategic planning for information and communications technology. He is also responsible for planning and developing all administrative and clinical information systems related to operating UC San Diego Health hospital and clinical facilities. Dr. Longhurst leads the creation and execution of a comprehensive information strategy to meet future needs of UC San Diego Health along with creating standards, architectures and policies for information technologies across UC San Diego and the UC system. His area of responsibility includes electronic health records and the MyUCSDChart system. UC San Diego Health has reached Stage 7 of electronic medical record (EMR) adoption, a ranking devised by the Healthcare Information and Management Systems Society (HIMSS). This distinction is achieved by less than five percent of U.S. hospitals. Dr. Longhurst is also a key faculty member in the Department of Biomedical Informatics in the UC San Diego School of Medicine. He most recently served as chief medical information officer for Stanford Children’s Health, where he led strategic efforts to improve children’s health and provider workflow using information technology. He also founded and led the clinical informatics fellowship at Stanford, where he was a clinical professor of pediatrics. Dr. Longhurst completed his residency at Stanford Medical School and earned his medical degree and MS in medical informatics from UC Davis. He holds a BS in molecular biology from UC San Diego. He is a board-certified pediatrician and clinical informaticist. The author and co-author of many publications on using technology and data to improve patient care and outcomes, Dr. Longhurst was elected a fellow in the prestigious American College of Medical Informatics.

Corporate Advisory Board

Ken Goulet

Ken Goulet is a senior-level health care executive with over 30 years of experience growing and leading large health plan organizations.

Most recently, Goulet served as the executive vice president of Anthem Inc., and president of the company’s Commercial and Specialty Business division—the largest Commercial Business Division in the United States.  Mr. Goulet also served in a variety of other executive leadership roles at Anthem, including president and CEO of the Employer, Medicaid, Individual and Specialty Business Unit; president and CEO of the former Commercial Business Unit and president and CEO of National Accounts. Before joining Anthem, Mr. Goulet spent 23 years at CIGNA Corporation where he held a number of management, sales and operations positions.

Mr. Goulet received a Bachelor of Arts degree in economics from Trinity College in Hartford, Connecticut.

Bob Kocher, MD

Bob Kocher is a Partner at Venrock and focuses on healthcare IT and services investments. He currently serves on the Board of Castlight Health and the Advisory Boards of Harvard Medical School Health Care Policy Department, USC Leonard D. Schaeffer Center for Health Policy and Economics where he is also a Senior Fellow, National Institute of Healthcare Management, and ChildObesity180. He is also a Non-Resident Senior Fellow at the Brookings Institution Engleberg Center for Health Reform and Co-Chair of the Health Data initiative, a joint effort of HHS and the Institute of Medicine, to release healthcare data to spur private sector innovation to improve healthcare cost and quality. Prior to Venrock, Bob served in the Obama Administration as Special Assistant to the President for Healthcare and Economic Policy on the National Economic Council.

Bob received undergraduate degrees from the University of Washington and a medical degree from George Washington University. He completed a research fellowship with the Howard Hughes Medical Institute and the National Institutes of Health, and went on to complete his internal medicine residency training at the Beth Israel Deaconess Medical Center and the Harvard Medical School. He is also a member of the Health Affairs Editorial Board and the not-for-profit Hope Street Group Board.

Lawrence B. Leisure

Larry Leisure is Co-founder and Managing Director of Chicago Pacific Founders, a private equity fund focused on senior living and care delivery services. He serves as Chairman of DC-based ADVI, which provides advisory services to the life sciences and managed care industries. He also acts as a Senior Advisor to the Silicon Valley venture capital firm, Kleiner Perkins Caufield & Byers.  

Larry’s extensive healthcare experience includes senior leadership roles at Accenture, PricewaterhouseCoopers, Towers Watson, Kaiser Foundation Health Plan, and UnitedHealth Group.

Larry also co-founded Healthspottr, a new media company focused on the acceleration of innovation in healthcare. He serves as a board member for several health-related companies including ConsejoSano, Lumiata, Recovery Ways and Xsell Technologies.He received his AB in Economics from Stanford University and his MBA in Finance from the University of California, Los Angeles.

Libby Sartain

Ms. Sartain is a leader in the field of human resources and employer branding. Throughout her distinguished 30 year career, Sartain was the head of Human Resources for both Yahoo! Inc. and Southwest Airlines guiding global human resources efforts to recruit, retain, and develop employees. During her tenure, she established the companies as leading employers and as one of Fortune 100 Best Companies To Work For in America and the Fortune 500. Sartain now serves as an active business advisor: she is on the Board of Directors at AARP, and consults with both startup companies as well as corporate clients.

Mike Christie

Mike is a 22-year veteran of the employer-sponsored health care and benefits business and has served as an executive-level sales and accounts leader in both startup and established industry environments. Most recently, Mike served as a member of the executive team at Grand Rounds, leading efforts to focus and scale the company’s go-to-market model. Mike was instrumental in expanding the company’s Fortune 50 customer roster and broad-based clinical navigation capabilities in the market. In 2018, Mike transitioned to a new role on the Advisory Board of Grand Rounds. Prior to Grand Rounds, Mike spent 20 years at Aon and Hewitt (acquired by Aon).

At Aon, Mike led the go-to-market efforts of several new, high-growth businesses, including the Aon Active and Retiree Health Exchanges. He was also a member of the Aon global Health leadership team, working with many of the firm’s largest clients on strategic health care development and helping to shape Aon’s Health business and solution strategy. During his years at Hewitt, Mike served in a variety of sales and leadership roles. Mike served for several years as one of the firm’s top sales executives, leading market development efforts for Hewitt’s large-market benefits administration services. He also helped launch the HR Business Process Outsourcing business and led national sales prior to Hewitt’s acquisition of Exult. Mike was also a founding member of Hewitt’s HR Effectiveness consulting practice, leading sales and consulting efforts on HR technology, transformation, and sourcing strategies.

In his various roles, Mike has often served as an industry thought leader, published expert, and frequent speaker.Mike holds a B.A. in journalism and philosophy from Marquette University.

John Lilly

John joined Greylock as a partner in 2011. John is currently on the Board of Directors of MessageMe, Clearslide, Citrus Lane, Code for America, and several unannouced investments. He leads Greylock’s investment in Dropbox and led investments in Tumblr (acquired by Yahoo in 2013) and Instagram (acquired by Facebook in 2012). John previously served on the boards of directors of TripIt (acquired by Concur in 2011), CenterRun (acquired by Sun Microsystems in 2003), and Reactivity (acquired by Cisco Systems in 2007).

Prior to Greylock, John was CEO of Mozilla, the organization behind Firefox, an open source Web browser used by more than 450 million people. John also co-founded Reactivity, an enterprise security infrastructure company acquired by Cisco in 2007, where he served as founding CEO and later CTO. Earlier in his career, John held positions on the executive team at Trilogy Software and as a Senior Scientist in Apple’s research labs.

John holds a BS in Computer Systems Engineering and an MS in Computer Science with a focus on Human Computer Interaction, both from Stanford University. He is a frequent contributor at Stanford’s, and an advisor to both the Stanford Technology Ventures Program and StartX, Stanford’s start up accelerator.

He is a co-inventor on seven United States patents.